IRIS Accounts Production v24.3.2.46 04336530 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false true false Ordinary 1.00000 Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh043365302023-12-31043365302024-12-31043365302024-01-012024-12-31043365302022-12-31043365302023-01-012023-12-31043365302023-12-3104336530ns15:EnglandWales2024-01-012024-12-3104336530ns14:PoundSterling2024-01-012024-12-3104336530ns10:Director12024-01-012024-12-3104336530ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3104336530ns10:SmallEntities2024-01-012024-12-3104336530ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3104336530ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3104336530ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3104336530ns10:FullAccounts2024-01-012024-12-3104336530ns10:OrdinaryShareClass12024-01-012024-12-3104336530ns10:Director22024-01-012024-12-3104336530ns10:CompanySecretary12024-01-012024-12-3104336530ns10:RegisteredOffice2024-01-012024-12-3104336530ns5:CurrentFinancialInstruments2024-12-3104336530ns5:CurrentFinancialInstruments2023-12-3104336530ns5:ShareCapital2024-12-3104336530ns5:ShareCapital2023-12-3104336530ns5:RetainedEarningsAccumulatedLosses2024-12-3104336530ns5:RetainedEarningsAccumulatedLosses2023-12-3104336530ns5:ComputerEquipment2023-12-3104336530ns5:ComputerEquipment2024-01-012024-12-3104336530ns5:ComputerEquipment2024-12-3104336530ns5:ComputerEquipment2023-12-3104336530ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3104336530ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3104336530ns10:OrdinaryShareClass12024-12-3104336530ns5:RetainedEarningsAccumulatedLosses2023-12-3104336530ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-31
REGISTERED NUMBER: 04336530 (England and Wales)















LONDON LUNG LABORATORY LIMITED

Unaudited Financial Statements

for the Year Ended 31 December 2024






LONDON LUNG LABORATORY LIMITED (REGISTERED NUMBER: 04336530)

Contents of the Financial Statements
for the year ended 31 December 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


LONDON LUNG LABORATORY LIMITED

Company Information
for the year ended 31 December 2024







Directors: R M Rudd
M G Britton



Secretary: R M Rudd



Registered office: 54 New Cavendish Street
London
W1G 8TQ



Registered number: 04336530 (England and Wales)



Accountants: Cooper Parry Advisory Limited
New Derwent House
69-73 Theobalds Road
London
WC1X 8TA



Bankers: Coutts & Co
440 Strand
London
WC2R 0QS

LONDON LUNG LABORATORY LIMITED (REGISTERED NUMBER: 04336530)

Balance Sheet
31 December 2024

2024 2023
Notes £ £
Fixed assets
Tangible assets 4 2,821 3,104

Current assets
Debtors 5 3,434 7,988
Cash at bank 21,539 17,394
24,973 25,382
Creditors
Amounts falling due within one year 6 (39,755 ) (37,706 )
Net current liabilities (14,782 ) (12,324 )
Total assets less current liabilities (11,961 ) (9,220 )

Capital and reserves
Called up share capital 7 100 100
Retained earnings 8 (12,061 ) (9,320 )
Shareholders' funds (11,961 ) (9,220 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 April 2025 and were signed on its behalf by:





R M Rudd - Director


LONDON LUNG LABORATORY LIMITED (REGISTERED NUMBER: 04336530)

Notes to the Financial Statements
for the year ended 31 December 2024


1. Statutory information

London Lung Laboratory Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 04336530 and the registered office address being 54 New Cavendish Street, London, W1G 8TQ.

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Key sources of estimation uncertainty and judgements
Preparation of the financial statements requires management to make significant judgements and estimates in determining the carrying amounts of certain assets and liabilities. Management makes assumptions of the effects of uncertain future events on those assets and liabilities at the balance sheet date. The management's estimates and assumptions are based on historical experience and expectation of future events and are reviewed periodically. This disclosure excludes uncertainty over future events and judgement in respect of measuring financial instruments. There are no further significant judgements or estimates.

Turnover
Turnover comprises revenue recognised by the company in respect of goods and services supplied during the year, exclusive of Value Added Tax.

Tangible fixed assets
Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Office equipment - 15% reducing balance

Going concern
The company meets its day to day working capital requirements through the support of the directors and shareholders of the company. On this basis, the directors consider it appropriate to prepare the financial statements on the going concern basis.

Financial instruments
Financial assets and financial liabilities are recognised in the balance sheet when the company becomes a party to the contractual provisions of the instrument.

Trade and other debtors and creditors are classified as basic financial instruments and measured at initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the company will not be able to collect all amounts due.

Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank, which are an integral part of the company's cash management.

3. Employees and directors

The average number of employees during the year was 1 (2023 - 1 ) .

LONDON LUNG LABORATORY LIMITED (REGISTERED NUMBER: 04336530)

Notes to the Financial Statements - continued
for the year ended 31 December 2024


4. Tangible fixed assets
Office
equipment
£
Cost
At 1 January 2024 34,110
Additions 215
At 31 December 2024 34,325
Depreciation
At 1 January 2024 31,006
Charge for year 498
At 31 December 2024 31,504
Net book value
At 31 December 2024 2,821
At 31 December 2023 3,104

5. Debtors: amounts falling due within one year
2024 2023
£ £
Trade debtors 3,434 7,988

6. Creditors: amounts falling due within one year
2024 2023
£ £
Taxation and social security 3,008 3,221
Other creditors 36,747 34,485
39,755 37,706

7. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £ £
100 Ordinary £1 100 100

8. Reserves
Retained
earnings
£

At 1 January 2024 (9,320 )
Deficit for the year (2,741 )
At 31 December 2024 (12,061 )

9. Related party disclosures

The company was under the control of the directors throughout the current and prior year.

At the balance sheet date, a director was owed £18,435 (2023: £18,435).